R1	Has_value Arg1:T1 Arg2:T2	
R2	Has_value Arg1:T3 Arg2:T4	
*	OR T7 T9 T8
R3	Has_value Arg1:T10 Arg2:T11	
R4	Has_value Arg1:T14 Arg2:T15	
R5	Has_value Arg1:T12 Arg2:T13	
*	OR T12 T14
R6	Has_value Arg1:T16 Arg2:T17	
R7	AND Arg1:T19 Arg2:T18	
*	OR T19 T20
R8	Has_temporal Arg1:T19 Arg2:T21	
R9	Has_value Arg1:T24 Arg2:T23	
*	OR T25 T26
R10	Has_value Arg1:T27 Arg2:T28	
R11	Has_qualifier Arg1:T29 Arg2:T30	
R12	Has_context Arg1:T29 Arg2:T27	
R13	Subsumes Arg1:T32 Arg2:T33	
R14	Has_value Arg1:T31 Arg2:T32	
T1	Measurement 0 3	mRS
T2	Value 3 5	=2
T3	Condition 19 25	stroke
T4	Value 26 41	within 3 months
T5	Condition 55 78	intracranial hemorrhage
T6	Condition 91 114	subarachnoid hemorrhage
T7	Condition 117 136	Intracranial tumour
T8	Condition 138 159	vascular malformation
T9	Condition 163 180	arterial aneurysm
T10	Procedure 183 196	Major surgery
T11	Value 197 211	within 1 month
T12	Measurement 214 231	Systolic pressure
T13	Value 232 241	=180 mmHg
T14	Measurement 245 263	diastolic pressure
T15	Value 264 273	=110 mmHg
T16	Measurement 276 290	Platelet count
T17	Value 291 300	< 105/mm3
T18	Drug 303 310	Heparin
T19	Procedure 311 318	therapy
T20	Procedure 322 350	oral anticoagulation therapy
T21	Temporal 351 366	within 48 hours
T23	Value 369 377	Abnormal
T24	Measurement 378 382	APTT
T25	Drug 385 393	Thrombin
T26	Drug 397 416	Xa factor inhibitor
T27	Observation 441 456	life expectancy
T28	Value 460 478	less than 3 months
T29	Condition 426 433	disease
T30	Qualifier 419 425	Severe
T31	Measurement 481 494	Blood glucose
T32	Value 495 505	< 50 mg/dL
T33	Value 507 516	2.7mmol/L
T34	Competing_trial 520 604	Patients who have received any other investigational drug or device within 3 months;
T35	Condition 606 615	Pregnancy
T36	Non-query-able 618 693	Researchers consider patients inappropriate to participate in the registry.
